IP Library Granted Patent US 8,828,680
Granted Patent B2
US 8,828,680 · App. 13/402,445 · Granted Sep 9, 2014

Combined rapid susceptibility assay and microorganism identification system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,828,680
App. No.
13/402,445
Granted
Sep 9, 2014
Kind
B2
Abstract

In response to the need for highly-sensitive antibiotic susceptibility assays and identification assays that do not require extensive incubation times, the present invention provides automated assay methods and systems that permit the determination of antibiotic susceptibilities and/or microorganism identification in a timeframe that is substantially shorter than has previously been attainable using a hybrid system that combines turbimetric and fluorescence determinations using a single, clear-plastic assay platform. Related devices, kits, and components thereof are also disclosed.

Claims (34)

1. A method for high throughput concurrent microorganism identification and antimicrobial susceptibility testing comprising:

a) inoculating one or more clear plastic panels having a plurality of wells with a sample to be tested for microorganism identification and antimicrobial susceptibility, wherein the one or more panels comprise a plastic microtiter plate having an opaque top surface and clear plastic wells for determining a microorganism's identification and a microorganism's susceptibility to at least one antimicrobial agent;

wherein the plurality of wells comprises at least one growth well, at least one minimum-inhibitory concentration (MIC) antimicrobial test well, and at least one control well;

wherein for microorganism identification, the at least one growth well contains an assay reagent, which when acted upon by a microorganism, is indicative of a microorganism family, genus and/or species;

wherein for antimicrobial susceptibility testing, the at least one MIC antimicrobial test well contains an antimicrobial agent;

b) placing the inoculated one or more clear plastic panels into an apparatus that maintains the inoculated one or more clear plastic panels at a predetermined temperature for a predetermined time;

c) incubating the inoculated one or more clear plastic panels in the apparatus at the predetermined temperature for a first predetermined time;

d) at a second predetermined time, performing a bichromatic collection process comprising:

i) transmitting a visible light wavelength through the at least one growth well,

ii) transmitting a fluorescent light wavelength through the at least one growth well using a read frame having a width optimized for use with clear plastic wells, wherein the visible light wavelength and the fluorescent light wavelength are distinct,

iii) collecting resulting visible light signals from the at least one growth well and converting the resultant visible light signals into a growth well turbidity reading, and

iv) collecting resultant fluorescent light signals from the at least one growth well using the read frame and converting the resultant fluorescent light signals into a growth well fluorescent reading;

e) determining the identity of the microorganism from the growth well turbidity reading and the growth well fluorescent reading;

f) determining the susceptibility of the microorganism to the antimicrobial agent in each of the at least one MIC antimicrobial test well by performing the following steps for each respective MIC antimicrobial test well:

i) setting read times for turbidity;

ii) setting thresholds for well growth;

iii) at a first read time, determining if a respective control well has growth;

iv) if the answer to iii) is yes, then recording a first turbidity reading from the respective control well and returning the plate to incubation;

v) if the answer to iii) is no, then returning the plate to incubation;

repeating steps vi)-viii) until a maximum read time is reached:

vi) at a next read time, determining if the respective control well has growth;

vii) if answer to vi) is yes, then recording a second turbidity reading from the respective control well and if the second turbidity reading is higher than the first turbidity reading and the second turbidity reading reached a first threshold for well growth, then recording the respective control well as growth;

viii) if the answer to vi) is no, then returning the plate to incubation;

ix) if the respective control well was recorded as growth in step vii), then determining if the respective MIC antimicrobial test well if has growth;

x) if the answer to ix) is yes, then determining and recording the turbidity of a respective growth well and the respective MIC antimicrobial test well and determine a ratio of turbidity of the respective MIC antimicrobial test well to turbidity of the respective growth well;

xi) if the ratio of step x) exceeds a threshold ratio level, then returning the plate to incubation;

xii) if the ratio of step x) is less than the threshold ratio level, then recording the concentration of the antimicrobial agent in the respective MIC antimicrobial test well as the minimum inhibitory concentration;

xiii) recording the turbidity of the respective growth well and the turbidity of the respective antimicrobial test well at a maximum read time;

xiv) reporting the recorded results and determining the susceptibility of the microorganism to the antimicrobial agent according to the reported results.

2. The method of claim 1 wherein the assay reagent is a growth requirement for a particular microorganism.

3. The method of claim 2 wherein the growth requirement is growth media specific for yeast, anaerobic bacteria, or fastidious bacteria.

4. The method of claim 2 wherein the growth well turbidity reading and the MIC antimicrobial test well turbidity reading are increased compared to a control well when the microorganism uses the growth requirement.

5. The method of claim 1 wherein the assay reagent is a substrate for an enzyme that is unique to a microorganism family, genus, and/or species.

6. The method of claim 5 wherein when the substrate is acted upon by the enzyme in a particular microorganism, a fluorescently detectable product is detected in step d).

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED ON REEL 034893 FRAME 0600. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE ADDRESS IS 250 S. KRAEMER BLVD., BREA, CALIFORNIA 92822. Recorded May 26, 2015
From: SIEMENS HEALTHCARE DIAGNOSTICS, INC.
To: BECKMAN COULTER, INC.
Reel/Frame 035771/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2015
From: SIEMENS HEALTHCARE DIAGNOSTICS, INC.
To: BECKMAN COULTER, INC.
Reel/Frame 034893/0600 →
MERGER Recorded Apr 4, 2012
From: DADE BEHRING INC.
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 027989/0929 →